In vivo studies of nanostructure-based photosensitizers for photodynamic cancer therapy

Small
Siew Hui VoonLip Yong Chung

Abstract

Animal models, particularly rodents, are major translational models for evaluating novel anticancer therapeutics. In this review, different types of nanostructure-based photosensitizers that have advanced into the in vivo evaluation stage for the photodynamic therapy (PDT) of cancer are described. This article focuses on the in vivo efficacies of the nanostructures as delivery agents and as energy transducers for photosensitizers in animal models. These materials are useful in overcoming solubility issues, lack of tumor specificity, and access to tumors deep in healthy tissue. At the end of this article, the opportunities made possible by these multiplexed nanostructure-based systems are summarized, as well as the considerable challenges associated with obtaining regulatory approval for such materials. The following questions are also addressed: (1) Is there a pressing demand for more nanoparticle materials? (2) What is the prognosis for regulatory approval of nanoparticles to be used in the clinic?

References

Jul 1, 1975·Journal of the National Cancer Institute·T J DoughertyD G Boyle
Oct 1, 1992·Photochemistry and Photobiology·D Kessel
Nov 18, 1991·Biochimica Et Biophysica Acta·D D LasicD Papahadjopoulos
Jan 1, 1989·Reviews on Environmental Health·D J King, R R Noss
Aug 1, 1989·Photochemistry and Photobiology·D Kessel
Dec 1, 1994·British Journal of Cancer·Y KubotaA Fujishima
Jan 1, 1994·Journal of Biomaterials Science. Polymer Edition·N L KrinickJ Kopecek
May 28, 1993·International Journal of Cancer. Journal International Du Cancer·E PontyG Soula
Jan 1, 1996·Journal of Photochemistry and Photobiology. B, Biology·M Ochsner
Apr 1, 1997·Photochemistry and Photobiology·F JiangM Chopp
Jan 24, 1998·Japanese Journal of Cancer Research : Gann·Y TabataY Ikada
Mar 4, 1998·Lasers in Surgery and Medicine·F JiangM Chopp
Jan 1, 1997·Journal of Clinical Laser Medicine & Surgery·J D BhawalkarP N Prasad
Oct 2, 1998·Pharmaceutical Research·L Illum
Jan 7, 1999·Drug Development and Industrial Pharmacy·O FeltR Gurny
Sep 2, 1999·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·M Jones, J Leroux
Oct 3, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M J GlantzS B Howell
Jun 7, 2000·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·J KopecekZ Lu
Mar 17, 2001·Advanced Drug Delivery Reviews·K KataokaY Nagasaki
Aug 31, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·H GelderblomA Sparreboom
May 29, 2002·Proceedings of the National Academy of Sciences of the United States of America·Kimmo PorkkaErkki Ruoslahti
Sep 5, 2002·International Journal of Cancer. Journal International Du Cancer·Antoon GijsensPeter de Witte
Sep 18, 2002·Proceedings of the National Academy of Sciences of the United States of America·Maria E AkermanErkki Ruoslahti
Jan 16, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·Janny X ZhangRon Boch
Feb 5, 2003·Advanced Drug Delivery Reviews·Richard B GreenwaldCharles D Conover
May 2, 2003·Nature Reviews. Cancer·Dennis E J G J DolmansRakesh K Jain
Sep 27, 2003·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Harubumi KatoHirohisa Horinouchi
Oct 16, 2003·Journal of the American Chemical Society·Yoko YamakoshiTetsuo Nagano
Nov 26, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·Guo-Dong ZhangKazunori Kataoka
Jan 7, 2004·Advanced Drug Delivery Reviews·Cornelus F van Nostrum
Jan 7, 2004·Advanced Drug Delivery Reviews·Annelies S L Derycke, Peter A M de Witte
Jan 23, 2004·Chemical Society Reviews·Ulrik Boas, Peter M H Heegaard
Apr 28, 2004·Advanced Drug Delivery Reviews·Anatoly N Lukyanov, Vladimir P Torchilin
May 12, 2004·Organic & Biomolecular Chemistry·Hiroshi Imahori

❮ Previous
Next ❯

Citations

Jan 6, 2016·International Journal of Molecular Sciences·Daniel L VegaJuan L Vivero-Escoto
Apr 27, 2016·Thoracic Surgery Clinics·Christopher S DigesuYolonda L Colson
Oct 28, 2016·Journal of the American Chemical Society·Ling HuangGang Han
Apr 5, 2017·Photochemistry and Photobiology·Stefano ProttiAlexander Greer
Feb 19, 2019·Small·Huijing Xiang, Yu Chen
Dec 6, 2018·Pharmaceuticals·Tuanwei Li, Lifeng Yan
Feb 3, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Maharajan SivasubramanianLeu-Wei Lo
May 6, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Daiana K DedaCelia R S Garcia
Jul 6, 2021·Chemical Society Reviews·Jianlei XieJong Seung Kim
Oct 20, 2017·Chemical Reviews·Wenpei FanXiaoyuan Chen
Sep 26, 2021·Advanced Science·Muhammad Rizwan YounisXing-Hua Xia

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer
Veronique BerardJohan E van Lier
Lasers in Surgery and Medicine
Cheng S Jin, Gang Zheng
© 2021 Meta ULC. All rights reserved